Mirae Asset Global Etfs Holdings Ltd. Ironwood Pharmaceuticals Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 84,431 shares of IRWD stock, worth $381,628. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84,431Holding current value
$381,628% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IRWD
# of Institutions
247Shares Held
171MCall Options Held
11.2MPut Options Held
28.5K-
Black Rock Inc. New York, NY22.9MShares$103 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$97.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$74.1 Million18.04% of portfolio
-
State Street Corp Boston, MA9.24MShares$41.8 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA8.91MShares$40.3 Million0.15% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $693M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...